CT2070/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF CANAKINUMAB 150MG/ML SOLUTION FOR INJECTION

TED · 394232-2026can-standardawardedNo deadline given

Buyer

NameDepartment of Contracts

CountryMT

Published2026-06-09

Deadline—

Estimated€10,547,578 · 10,547,578 EUR

Awarded€10,056,992 · 10,056,992.4 EUR

WinnerV.J. Salomone Pharma Limited

33690000 Medical equipment & pharmaceuticals

CT2070/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF CANAKINUMAB 150MG/ML SOLUTION FOR INJECTION

Closest by meaning — across languages, via embeddings.

Published	Title	Buyer	Match
2026-05-06	CT2296/2025 - Framework Contract for the supply of Brentuximab 50mg powder for concentrate for solution for injection	Department of Contracts MT	93%
2026-04-30	CT2096/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF INSULIN DEGLUDEC 100 IU/ML SOLUTION FOR INJECTION	Department of Contracts MT	92%
2026-06-03	CT2377/2025 - Framework Contract for the supply of Ustekinumab 45mg Solution for Injection, Ustekinumab 90mg Solution for Injection , and Ustekinumab 130mg Concentrate for Solution for Infusion	Department of Contracts MT	92%
2026-06-09	CT2116/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF BENDROFLUMETHIAZIDE (BENDROFLUAZIDE) 5MG TABLETS/CAPSULES	Department of Contracts MT	92%
2026-05-28	CT2117/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF DISULFIRAM 200MG TABLETS	Department of Contracts MT	92%
2026-06-09	CT2181/2026 - Framework Contract for the supply of Fulvestrant 250mg solution for injection	Department of Contracts MT	92%